A prodrome is a warning phase of early symptoms or changes that appear before a disease or medical event fully declares itself. The term comes from the Greek “prodromos,” meaning forerunner, and it applies across an enormous range of conditions, from the fatigue that precedes a cold to subtle behavioral shifts that can show up years before a neurological diagnosis. Prodromes vary wildly in how useful they are: some give you hours of notice, others give you years, and recognizing them can change treatment decisions in ways that matter.
How Prodromes Differ from Symptoms
The distinction between a prodrome and a symptom matters clinically, even if it feels like splitting hairs. A symptom belongs to the disease itself. A prodrome happens before the disease has fully arrived but is nonetheless caused by the same underlying process. If you get a tingling sensation on your lip and a cold sore breaks out the next day, that tingling was the prodrome. The blister is the symptom. In practice, the line between “early symptom” and “prodromal sign” gets blurry, especially in chronic diseases where onset is gradual. Researchers sometimes use terms like “premonitory phase” or “pre-motor stage” interchangeably with prodrome, depending on the field.
What makes prodromes clinically interesting is their timing. If you can reliably identify a prodrome, you sometimes get a window to intervene, whether that means taking medication, adjusting behavior, or simply being prepared. That window ranges from minutes to decades, depending on the condition.
Epilepsy and the Short-Fuse Prodrome
People with epilepsy sometimes sense that a seizure is coming, and this pre-seizure state has been studied more systematically than many people realize. Across eight studies examining how common the epilepsy prodrome is, the average prevalence was about 22%. The most frequently reported feelings were a vague “funny feeling,” confusion, anxiety, and irritability. Duration ranged widely, from about ten minutes to three days, though most prodromes lasted somewhere between half an hour and a full day. When researchers narrowed the question to a single dominant prodromal symptom, headache was the most commonly reported, appearing in roughly 8% of cases.
1PubMed Central. Prodrome in epilepsyMore recent research has explored whether temporary changes in smell might serve as a prodromal marker in temporal lobe epilepsy specifically, since the brain regions involved in olfaction overlap with those involved in seizure generation. This is early-stage work, but the idea that transient olfactory impairment could flag an approaching seizure is being actively investigated.
2PubMed. Who ‘nose’ when a seizure will happen? Prodromal olfactory loss as a first clinical indicator of seizure activity in temporal lobe epilepsyInterestingly, prodromal behavior before seizures is not unique to humans. A study of dogs with idiopathic epilepsy found that nearly two-thirds of owners reported prodromal changes, with the most common being restlessness, increased clinginess, and fearful behavior.
3PubMed. Investigating the potential for seizure prediction in dogs with idiopathic epilepsy: owner-reported prodromal changes and seizure triggersMigraine and Its Premonitory Phase
Migraine offers one of the best-known examples of a prodrome in everyday life. Many migraine sufferers experience premonitory symptoms hours before the headache itself arrives: yawning, food cravings, neck stiffness, mood changes, or difficulty concentrating. This phase is distinct from the aura (the visual disturbances some people get), which tends to occur closer to the headache onset.
Neuroimaging research has pointed to the hypothalamus as a key driver of the premonitory phase, with studies showing hypothalamic activation during this period. However, the evidence base here is thinner than it looks. A review of the available neuroimaging studies found that the research was limited by methodological issues, inconsistent reporting, and a lack of adherence to standard definitions of premonitory symptoms in experimental studies.
4PubMed Central. The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidenceFor the person living with migraine, the practical upside of recognizing a prodrome is that some medications work better when taken early. If you know your pattern well enough to catch the premonitory phase, you may get more out of an abortive treatment than if you wait for the headache to build.
Parkinson’s Disease and the Decade-Long Lead Time
The prodrome for Parkinson’s disease operates on a completely different timescale from epilepsy or migraine. Certain non-motor symptoms can appear years or even decades before the tremor, stiffness, and slowness of movement that lead to a diagnosis. The two most prominent early markers are REM sleep behavior disorder, a condition where people physically act out their dreams, and a reduced sense of smell.
5PubMed Central. Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s DiseaseOther prodromal features include constipation, depression, and excessive daytime sleepiness. The catch is that these are all extremely common complaints in the general population, and in most cases they have nothing to do with Parkinson’s. A person who is constipated and a little depressed overwhelmingly does not have early Parkinson’s. REM sleep behavior disorder stands out because it is far less common in the general population, and most people who develop it do eventually go on to develop Parkinson’s or a related condition.
6PubMed. Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal featuresResearch has also confirmed that people with reduced smell are significantly more likely to report other non-motor features like anxiety, depression, constipation, and REM sleep behavior disorder symptoms, suggesting these prodromal features tend to cluster together.
7PubMed Central. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAlzheimer’s Disease and Subjective Cognitive Decline
Alzheimer’s disease has its own form of prodrome, though it is harder to pin down. There is growing evidence that subjective cognitive decline, the feeling that your memory or thinking is slipping even though you still perform normally on cognitive tests, may represent the earliest symptomatic stage of Alzheimer’s. A framework proposed by an international working group treats this self-reported decline as a potential first clinical sign of the disease process, especially when it begins after age 60 and the person expresses worry about it.
8PubMed Central. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s diseaseThe challenge is obvious: plenty of healthy people notice their memory getting worse with age, and most of them do not develop Alzheimer’s. Blood-based biomarkers for the proteins involved in Alzheimer’s pathology, including amyloid and tau, are being developed to help distinguish prodromal Alzheimer’s from normal aging. These markers are not yet in routine clinical use, but research has demonstrated robust assays that can detect key pathological changes in blood samples, potentially allowing screening or monitoring in the future.
9PubMed Central. Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical NeurologistPsychiatric Prodromes
In psychiatry, the concept of a prodrome has been especially influential in research on schizophrenia and bipolar disorder. Both conditions typically emerge in late adolescence or early adulthood, and in both cases there is often a recognizable lead-up period of milder symptoms.
Schizophrenia
Before a first episode of psychosis, many people go through a period of subtle changes: social withdrawal, unusual ideas, difficulty concentrating, sleep disruption, and declining functioning at school or work. Identifying this prodromal phase has been a major research focus because if you can intervene during this window, you might delay or prevent the first psychotic episode. One randomized controlled trial tested a specific preventive intervention, including low-dose antipsychotic medication and cognitive therapy, against standard needs-based care. By the end of treatment, roughly a third of those receiving standard care had progressed to a first psychotic episode, compared to about one in ten in the specific intervention group. After treatment stopped, the difference narrowed, though patients who had adhered to the medication maintained protection for an additional six months.
10JAMA Psychiatry. Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold SymptomsThe schizophrenia prodrome has been described as developmentally complex, consisting of distinct subgroups that respond differently to treatment. Not everyone in the prodromal phase progresses to full psychosis, which introduces a serious ethical problem: you may be giving antipsychotic medications, with their side effects, to people who would never have become psychotic. This tension between early intervention and overtreatment has been a central concern in the field.
11PubMed Central. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future researchBipolar Disorder
Before a first manic episode, young people often experience a period marked by mood fluctuation, sleep disturbance, irritability, and declining school or work performance.
12PubMed. The proximal prodrome to first episode mania–a new target for early intervention A systematic review of the bipolar prodrome found that irritability, aggressiveness, sleep problems, depression and mania symptoms, hyperactivity, anxiety, and mood swings were common early clusters. As the full onset approached, symptoms of mania and depression tended to increase gradually in strength.
13PubMed. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic reviewA study of youth with bipolar I disorder looked at which specific prodromal symptoms appeared before the first manic episode. Among the most common were irritability (reported by about 62% of youth), decreased functioning at school or work (65%), racing thoughts (60%), mood swings (58%), and depressed mood (54%). When the researchers focused on symptoms more specifically linked to mania, like elation, grandiosity, or decreased need for sleep, about 85% of youth had at least one of these, but the proportion dropped sharply when requiring two or three such symptoms to be present simultaneously.
14PubMed Central. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episodeHeart Attack Warning Signs That Start Weeks Before
Prodromes are not limited to neurological and psychiatric conditions. Heart attacks frequently have a prodromal phase that many people fail to recognize, partly because it does not always look like what we expect a heart problem to feel like. A landmark study of 515 women diagnosed with acute myocardial infarction found that 95% reported prodromal symptoms more than a month before the event. The most frequent were unusual fatigue (reported by about 71%), sleep disturbance (48%), and shortness of breath (42%). Only about 30% reported chest discomfort during this prodromal phase.
15PubMed. Women’s early warning symptoms of acute myocardial infarctionAnother study of over 500 patients found that fatigue in the year before a heart attack was reported by about 62%, shoulder or back pain by 51%, and chest pain by 45%. This study also looked at whether prodromal symptoms predicted what happened during the acute event. The results were striking: people who had experienced prodromal chest pain were several times more likely to have chest symptoms during the heart attack itself. A similar pattern held for arm pain, shortness of breath, and fatigue. The prodromal pattern, in other words, tended to preview the acute pattern.
16PubMed. Early warning signs of an acute myocardial infarction and their influence on symptoms during the acute phase, with comparisons by genderThe practical implication is straightforward: if you develop new, unexplained fatigue, sleep problems, or vague chest or shoulder discomfort that persists for weeks, especially if you have cardiovascular risk factors, it is worth mentioning to your doctor even if you do not think you are having a heart attack. These symptoms are easy to dismiss, and frequently are dismissed, but they can be the body’s early alarm.
Infectious Disease Prodromes
Most people have experienced an infectious disease prodrome without knowing the term. The scratchy throat and fatigue that come a day before a full-blown cold, or the malaise and body aches that precede a flu, are classic prodromal symptoms driven by your immune system ramping up its inflammatory response.
Shingles offers a particularly well-documented example. Before the characteristic painful rash appears, many people experience localized pain, tingling, or burning in the area where the rash will erupt. A study of patients who developed shingles on the head or face found that about 74% experienced preeruptive pain, lasting an average of three days. The pain was almost always on the same side as the eventual rash, was moderate to severe in about 90% of cases, and was typically stabbing in nature. For the vast majority of patients, this type of pain was something they had never experienced before.
17PubMed. Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the headThe diagnostic challenge with shingles prodromes is that without the rash to confirm the diagnosis, the pain can be mistaken for a dental problem, a tension headache, or trigeminal neuralgia, depending on where it occurs. Antiviral treatment for shingles works best when started early, so recognizing the prodromal pain pattern can meaningfully affect outcomes.
Rheumatoid Arthritis and the Autoantibody Window
Rheumatoid arthritis (RA) has an immunological prodrome that is invisible to the patient. Years before joint inflammation becomes clinically apparent, certain autoantibodies can be detected in the blood. Among these, anti-citrullinated protein antibodies (ACPA) carry the highest risk and can appear well before any visible joint swelling.
18PubMed Central. Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel FindingsA study of serial blood samples from blood donors who later developed RA found that roughly half had detectable antibody abnormalities years before their first symptoms. The researchers concluded that finding elevated levels of certain antibodies in an otherwise healthy person implies a high risk of eventually developing RA.
19PubMed. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors By the time symptoms finally appear, a broad range of autoantibody types is typically present, suggesting that the immune process has been building for a long time.
20PubMed. An overview of autoantibodies in rheumatoid arthritisThis raises an interesting practical question: should you screen healthy people for RA autoantibodies? The answer, for now, is generally no in routine care, because most screening would happen in people without significant risk factors, and a positive result in someone without symptoms creates anxiety without a clear treatment path. However, in people with strong family histories or suggestive early symptoms, antibody testing can help identify those who might benefit from close monitoring.
Technology and the Future of Prodrome Detection
One of the more intriguing frontiers in prodrome research is the use of wearable devices and machine learning to detect physiological changes before people feel sick. A study using smartwatch data found that altered physiology associated with COVID-19 could be detected in advance of symptoms.
21Nature Biomedical Engineering. Pre-symptomatic detection of COVID-19 from smartwatch data Separately, researchers demonstrated that wearable biometric data could predict H1N1 infection status 24 to 36 hours before symptom onset, with most models achieving greater than 80% accuracy.
22JAMA Network Open. Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom OnsetOn the neurodegenerative side, researchers have used machine learning applied to electronic health records to predict a multiple sclerosis diagnosis three years before it was made, achieving strong accuracy by combining medical record patterns with a biological knowledge network.
23Journal of the American Medical Informatics Association. Embedding electronic health records onto a knowledge network recognizes prodromal features of multiple sclerosis and predicts diagnosis Similar approaches have been applied to Alzheimer’s disease, where algorithms trained on healthcare claims data from the years before diagnosis can identify patterns that flag prodromal cases.
24PubMed. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer’s Disease Patients in the General PopulationThese tools are not in routine clinical use yet. But they represent a shift in how we think about prodromes, from something a patient reports to something an algorithm detects in data the patient generates passively. The appeal is obvious: earlier detection, earlier treatment. The risk is equally clear, particularly the possibility of generating false alarms and unnecessary anxiety, the same ethical tension that runs through prodromal research in psychiatry.
Why the Body Produces Prodromal Symptoms at All
There is an evolutionary lens through which prodromes make more sense. The malaise, fatigue, loss of appetite, and social withdrawal that precede many infectious illnesses are not just the body failing to cope. Researchers have come to understand this cluster, known as sickness behavior, as the expression of a motivational state, a coordinated biological program that reorganizes behavior in the face of a microbial threat, much the way fear reorganizes behavior in the presence of a predator.
25PubMed Central. Evolutionary Aspects of Infections: Inflammation and Sickness BehaviorsSickness behavior is triggered by the same inflammatory signaling molecules that drive fever, and it serves a complementary purpose. By making you feel too tired to move around, too uninterested in food to forage, and too antisocial to seek contact, it redirects energy toward the immune response while also reducing your exposure to additional threats. This redirecting of energy appears to be modulated by hormones, and the whole system sits at the intersection of immunology, endocrinology, and evolutionary biology.
26PubMed. Human sickness behavior: Ultimate and proximate explanationsNot all prodromes fit neatly into this adaptive framework. The prodromal symptoms of a heart attack or a seizure are not obviously serving a protective function; they are more like leakage from a process that is already going wrong. But for infectious illness, the prodromal phase is not just a preview of being sick. It is the body actively doing something useful.